#jideytro — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #jideytro, aggregated by home.social.
-
GSK Lands Its First Lung Cancer Drug Days After Nuvalent Deal Closes — BigGo Finance
GSK had never won FDA approval for a lung cancer drug — not in decades of trying. Then,…
#EuropeSays #Britain #Europe #EU #GSK #AxiomBiosciences #FDA #FierceBiotech #HongKongExchange #Jideytro #MarissaRusso #nasdaq #Nuvalent #TheTopLine #U.S.HouseofRepresentatives
https://www.europesays.com/britain/89781/ -
https://www.europesays.com/britain/89781/ GSK Lands Its First Lung Cancer Drug Days After Nuvalent Deal Closes — BigGo Finance #AxiomBiosciences #FDA #FierceBiotech #GSK #HongKongExchange #Jideytro #MarissaRusso #nasdaq #Nuvalent #TheTopLine #USHouseOfRepresentatives
-
GSK (LSE:GSK) Wins FDA Nod For Jideytro As Bexsero And Jemperli Advance
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors…
#EuropeSays #Britain #Europe #EU #GSK #Bexsero #Jemperli #Jideytro #Lungcancer #meningococcaldisease #Oncology #rectalcancer
https://www.europesays.com/britain/89247/ -
https://www.europesays.com/britain/89247/ GSK (LSE:GSK) Wins FDA Nod For Jideytro As Bexsero And Jemperli Advance #Bexsero #GSK #Jemperli #Jideytro #LungCancer #MeningococcalDisease #Oncology #RectalCancer
-
GSK FDA Approves Jideytro; 44% Response Rate
Approval based on ARROS-1 phase I/II trial demonstrating meaningful and durable responses in patients with locally advanced or…
#EuropeSays #Britain #Europe #EU #GSK #FDAapproval #GSKticker #Jideytro #Lungcancer #Oncology #ROS1-positiveNSCLC #zidesamtinib
https://www.europesays.com/britain/89049/ -
https://www.europesays.com/britain/89049/ GSK FDA Approves Jideytro; 44% Response Rate #FDAApproval #GSK #GSKTicker #Jideytro #LungCancer #Oncology #ROS1PositiveNSCLC #zidesamtinib
-
GSK Lands FDA Approval for Nuvalent-Acquired Jideytro for NSCLC
GSK plc GSK announced that the FDA has approved Jideytro (zidesamtinib) for previously treated ROS1-positive non-small cell lung…
#EuropeSays #Britain #Europe #EU #GSK #FDA #GSKplc #Jideytro #NeurocrineBiosciences #non-smallcelllungcancer #ZacksInvestmentResearch #ZacksRank
https://www.europesays.com/britain/88972/ -
https://www.europesays.com/britain/88972/ GSK Lands FDA Approval for Nuvalent-Acquired Jideytro for NSCLC #FDA #GSK #GSKPlc #Jideytro #NeurocrineBiosciences #NonSmallCellLungCancer #ZacksInvestmentResearch #ZacksRank
-
GSK wins FDA nod for Jideytro lung cancer drug | GSK SEC Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER…
#EuropeSays #Britain #Europe #EU #GSK #ARROS-1clinicaltrial #FDAapproval #GSK6-K #Jideytro #Nuvalentacquisition #OncologyDrug #ROS1-positiveNSCLC #zidesamtinib
https://www.europesays.com/britain/88610/ -
https://www.europesays.com/britain/88610/ GSK wins FDA nod for Jideytro lung cancer drug | GSK SEC Filing #ARROS1ClinicalTrial #FDAApproval #GSK #GSK6K #Jideytro #NuvalentAcquisition #OncologyDrug #ROS1PositiveNSCLC #zidesamtinib